Allogene Therapeutics, Inc.
NASDAQ:ALLOBiotechnology
Healthcare
$0.74 +1.02%
+$0.02 today
- Market cap
- $257.81M
- Beta
- 0.46
- P/E (TTM)
- -2.7
- EPS (TTM)
- -$0.72
52W Low $0.98High $4.46
Volume 8.49M
Average 10.19M
Price history
Allogene Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-43.20%
Period high
$3.06
Period low
$0.74
Latest
$0.74
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 10-Q | Nov 6, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| SC 13G/A | Oct 27, 2026 | Oct 27, 2026 | |
| 4 | Oct 23, 2026 | Oct 23, 2026 | |
| SC 13D/A | Sep 30, 2026 | Sep 30, 2026 | |
| 8-K | Sep 2, 2026 | Sep 2, 2026 | |
| 4 | Aug 25, 2026 | Aug 25, 2026 | |
| EFFECT | Aug 20, 2026 | Aug 21, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 10-Q | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Aug 12, 2026 | Aug 12, 2026 | |
| S-3 | Aug 12, 2026 | Aug 12, 2026 | |
| SC 13G | Aug 7, 2026 | Aug 7, 2026 | |
| SC 13G/A | Aug 7, 2026 | Aug 7, 2026 |
Competitors
Who does Allogene Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about ALLO's filings, answered from its disclosures.
What is the latest ALLO filing?
The latest filing shown is SC 13G dated Nov 10, 2026.
How many recent filings does ALLO have?
Intrinsic Alpha currently shows 20 recent filings for ALLO.
Continue the stock analysis
Jump to another research area for this company.